BIRC5 and pancreatic adenocarcinoma: Gemcitabine treatment of mice bearing established Panc02 pancreatic adenocarcinomas prior to administration of a modified Vaccinia Ankara (MVA) based viral vaccine against the murine survivin protein led to the greatest reduction in tumor volume compared to controls [15].